Kidney health for all: caring for people, protecting the planet
DOI:
https://doi.org/10.52786/isu.a.120Keywords:
Environment, green nephrology, prevention, screening, sustainable kidney care, World Kidney DayAbstract
The current kidney care model with its focus on late-stage disease and in-center hemo-dialysis is unsustainable, largely because of costs, environmental burden, poor outcomes, and reduced quality of life. Recognition of kidney disease by the 78th World Health Assembly as a serious health threat presents a critical opportunity to reshape kidney care. Aligned with this, the 2026 World Kidney Day theme, “Kidney Health for All: Caring for People, Protecting the Planet”, calls for a systematic change. A sustainable model must prioritize early detection and prevention, reducing the need for kidney replacement therapy. Transplantation and home dialysis benefit people with kidney failure, environment and society, however, dialysis itself must become more eco-friendly without compromising care quality, recognizing that planetary perturbations in turn affect kidney health. Conservative care should also be considered, particularly in the case of elderly and frail patients when the quality-of-life benefits potentially out-weigh the perspectives offered by dialysis. Achieving this shift requires coordinated action across all stakeholders; education and engagement of the public, policy makers and health professionals to raise awareness about the threat of kidney disease; and an urgent move toward patient-centered care.
References
Francis A, Harhay MN, Ong ACM, Tummalapalli SL, Ortiz A, Fogo AB, et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol 2024;20:473-85.
GBD 2023 Kidney Failure with Replacment Therapy Collaborators. Global, regional, and national prev- alence of kidney failure with replacement therapy and associated aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Glob Health 2025;13:e1378-95.
Vanholder R, Annemans L, Bello AK, Bikbov B, Gal- lego D, Gansevoort RT, et al. Fighting the unbearable lightness of neglecting kidney health: the decade of the kidney. Clin Kidney J 2021;14:1719-30.
Vanholder R, Annemans L, Braks M, Brown EA, Pais P, Purnell TS, et al. Inequities in kidney health and kidney care. Nat Rev Nephrol 2023;19:694-708.
World Health Organization. Reducing the burden of noncommunicable diseases through promotion of kidney health and strengthening prevention and control of kidney disease [Internet]. 2026 [cited 2026 Jan 12]. Available from: https://apps.who.int/ gb/ebwha/pdf_files/EB156/B156_(20)-en.pdf
Vanholder R, Agar J, Braks M, Gallego D, Gerritsen KGF, Harber M, et al. The European Green Deal and nephrology: a call for action by the European Kidney Health Alliance. Nephrol Dial Transplant 2023;38:1080-8.
Vanholder R, Coppo R, Bos WJW, Damato E, Fak- houri F, Humphreys A, et al. A policy call to address rare kidney disease in health care plans. Clin J Am Soc Nephrol 2023;18:1510-8.
Gregg EW. Diabetes-related disability as a target for prevention. Lancet Diabetes Endocrinol 2013;1:81-2.
Vanholder R, Annemans L, Brown E, Gansevoort R, Gout-Zwart JJ, Lameire N, et al. Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol
;13:393-409.
World Kidney Day. 8 golden rules animated visuals [Internet]. 2026. [cited 2026 Jan 12]. Available from: https://www.worldkidneyday.org/facts/8-golden-rules/
Norton JM, Moxey-Mims MM, Eggers PW, Narva 23. AS, Star RA, Kimmel PL, et al. Social determinants of racial disparities in CKD. J Am Soc Nephrol 2016;24. 27:2576-95.
Ferro CJ, Wanner C, Luyckx V, Stevens K, Cerqueira S, Darwish R, et al. ABCDE to identify and prevent chronic kidney disease: a call to action. Nephrol Dial Transplant 2025;40:1786-98.25.
Heerspink HJ, Desai M, Jardine M, Balis D, Meininger G, Perkovic V. Canagliflozin slows progression of renal function decline independently of glycemic effects. J Am Soc Nephrol 2017;28:368-75.
Cordero L, Ortiz A. Albuminuria-based universal 26. screening for CKD should be implemented now in high-income countries. Kidney Int 2025;108:754-9.
Stehle T, Delanaye P. Which is the best glomerular filtration marker: creatinine, cystatin C or both? Eur J Clin Invest 2024;54:e14278.
van Mil D, Kieneker LM, Evers-Roeten B, Thelen MH, de Vries H, Hemmelder MH, Dorgelo A, et
al. Participation rate and yield of two home-based screening methods to detect increased albumin-
uria in the general population in the Netherlands (THOMAS): a prospective, randomised, open-label implementation study. Lancet 2023;402:1052-64.
Tangri N, Alvarez CS, Arnold M, Barone S, Cebrián A, Chen H, et al. Suboptimal monitoring and management in patients with unrecorded stage 3 chronic kidney disease in real-world settings: insights from REVEAL-CKD. Eur J Clin Invest 2024;54:e14282.
Pouwels X, van Mil D, Kieneker LM, Boersma C, van Etten RW, Evers-Roeten B, et al. Cost-effectiveness of home-based screening of the general population for albuminuria to prevent progression of cardiovascular and kidney disease. EClinicalMedicine 2024;68:102414.
Chavarina KK, Lou-Meda R, Luyckx VA. Strategic rebalancing of kidney-related investments is key to implementing the WHO kidney health resolution. Nat Rev Nephrol 2025;21:813–4.
Kidney Disease Screening and Awareness Program. Together we fight kidney disease [Internet]. 2026. [cited 2026 Jan 12]. Avaiable from: www.kdsap.org.
Afkarian M, Sachs MC, Kestenbaum B, Hirsch IB, Tuttle KR, Himmelfrarb J, et al. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol 2013;24:302-8.
Wan EYF, Yu EYT, Chin WY, Fong DYT, Choi EPH, Tang EHM, et al. Burden of CKD and cardiovascular disease on life expectancy and health service utilization: a cohort study of Hong Kong Chinese hypertensive patients. J Am Soc Nephrol 2019;30:1991-9.
Luyckx VA, Ulasi II. Kidney disease must be counted everywhere. Lancet 2025;406:2401-3.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 2024; 105:S117-314.
Rama Krishna C, Venkateswar S, Bogdan M, Begos D, Kemisetti S, Chintagunti NK, et al. Point-of-care testing and integrated digital health technology for CKD screening in high-risk populations of India. Kidney Int Rep 2025;10:2128-39.
Guedes M, Dias PT, Rea RR, Caice-Silva V, Lopes M, Brandão AA, et al. Patterns of kidney function and risk assessment in a nationwide laboratory database: the Brazilian CHECK-CKD study. BMC Nephrol 2024;25:191.
Hajat S, Casula A, Murage P, Omoyeni D, Gray T, Plummer Z, et al. Ambient heat and acute kidney injury: case-crossover analysis of 1 354 675 automated e-alert episodes linked to high-resolution climate data. Lancet Planet Health 2024;8:e156-62.
Maline GE, Goldfarb DS. Climate change and kidey stones. Curr Opin Nephrol Hypertension 2024; 33:89-96.
Gopalakrishnan N, Sudharshini S, Sakthirajan R, Dineshkumar T, Lamech TM, Somasundaram A, et al. CKDu-AGRI study-a population-based cross-sectional study of chronic kidney disease and chronic kidney disease of unknown aetiology among agricultural workers in Tamil Nadu, India. Lancet Reg Health Southeast Asia 2025;42:100683.
Garcia-Trabanino RA. The human burden of Mesoamerican nephropathy: diagnosis and treatment in a complex web of socioeconomics, context, and stigma. Semin Nephrol 2025;45:151601.
Chretien JP, Anyamba A, Small J, Britch S, Sanchez JL, Halbach AC, et al. Global climate anomalies and potential infectious disease risks: 2014-2015. PLoS Curr 2015;7:ecurrents.outbreaks.95fbc4a8fb4695e- 049baabfc2fc8289f.
Bowe B, Artimovich E, Xie Y, Yan Y, Cai M, Al-Aly Z. The global and national burden of chronic kidney disease attributable to ambient fine particulate matter air pollution: a modelling study. BMJ Glob Health 2020;5:e002063.
World Meteorological Organization, World Health Organization. Alliance for Transformative Action on Climate and Health (ATACH) meeting on accessing climate finance for health [Internet]. 2026. [cited 2026 Jan 12]. Avaiable from: https://climahealth. info/alliance-for-transformative-action-on-climate-and-health-atach-meeting-on-accessing-climate-finance-for-health/
Talbot B, Fletcher RA, Neal B, Oshima M, Adshead F, Moore K, et al. The potential for reducing green-house gas emissions through disease prevention: a secondary analysis of data from the CREDENCE trial. Lancet Planet Health 2024;8:e1055-64.
Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants with Diabetic Nephropathy (CREDENCE). ClinicalTri- als.gov identifier: NCT02065791 [Internet]. 2019. [cited 2026 Jan 12]. Available from: https://clini-caltrials.gov/study/NCT02065791
Vanholder R, Dominguez-Gil B, Busic M, Cortez-Pinto H, Craig JC, Jager KJ, et al. Organ donation and transplantation: a multi-stakeholder call to action. Nat Rev Nephrol 2021;17:554-68.
Tonelli M, Wiebe N, Knoll G, Bello A, Browne S, Jadhav D, et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant 2011;11:2093-109.
Schaapherder A, Wijermars LGM, de Vries DK, de Vries APJ, Bemelman FJ, van de Wetering J, et al. Equivalent long-term transplantation outcomes for kidneys donated after brain death and cardiac death: conclusions from a nationwide evaluation. EClinicalMedicine 2018;4-5:25-31.
Azegami T, Kounoue N, Sofue T, Yazawa M, Tsujita M,MasutaniK,etal.Efficacyofpre-emptivekidney transplantation for adults with end-stage kidney disease: a systematic review and meta-analysis. Renal Fail 2023;45:2169618.
Achkar KA, Abdelnour LM, Abu Jawdeh BG, Tantisattamoa E, Ammary FA. Evaluation and long-term follow-up of living kidney donors. Adv Kidney Dis Health 2024;31:400-7.
Barraclough KA, Agar JWM. Green nephrology. Nat Rev Nephrol 2020;16:257-68.
Lenzen M, Malik A, Li M, Fry J, Weisz H, Picher P, et al. The environmental footprint of health care: a global assessment. Lancet Planet Health 2020;4: e271-9.
Connor A, Lillywhite R, Cooke MW. The carbon footprint of a renal service in the United Kingdom. QJM 2010;103:965-75.
Piccoli GB, Nazha M, Ferraresi M, Vigotti FN, Pereno A, Barbero S. Eco-dialysis: the financial and ecological costs of dialysis waste products: is a “cradle-to-cradle” model feasible for planet-friendly haemodialysis waste management? Nephrol Dial Transplant 2015;30:1018-27.
Tarrass F, Benjelloun M, Benjelloun O. Recycling wastewater after hemodialysis: an environmental analysis for alternative water sources in arid regions. Am J Kidney Dis 2008;52:154-8.
McAlister S, Talbot B, Knight J, Blair S, Mcgain F, McDonald S, et al. The carbon footprint of perito- neal dialysis in Australia. J Am Soc Nephrol 2024; 35:1095-103.
Barraclough KA, Talbot B, Knight J, Blair S, McGain F, Masterson R, et al. Carbon emissions from different dialysis modalities: a life cycle assessment. Am J Kidney Dis 2025;86:465-74.e1.
Solomon D, Arumugam V, Sakthirajan R, Lamech TM, Dineshkumar T, Vathsalyan P, et al. A pilot study on the safety and adequacy of a novel ecof- riendly hemodialysis prescription-green nephrology. Kidney Int Rep 2024;9:1496-503.
Ramada DL, de Vries J, Vollenbroek J, Noor N, Beek OT, Mihãilã S, et al. Portable, wearable and implantable artificial kidney systems: needs, opportunities and challenges. Nat Rev Nephrol 2023;19:481-90.
Lunney M, Bello AK, Levin A, Tam-Tham H, Thomas C, Osman MA, et al. Availability, accessibility, and quality of conservative kidney management worldwide. Clin J Am Soc Nephrol 2020;16:79-87.
Tamura MK, Covinsky KE, Chertow GM, Yaffe K, Landefeld CS, McCulloch CE. Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 2009;361:1539-47.
Morton RL, Snelling P, Webster AC, Rose J, Masterson R,Johnson DW, etal. Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease. CMAJ 2012;184:E277-83.
Stel VS, de Jong RW, Kramer A, Andrusev AM, Baltar JM, Barbullushi M, et al. Supplemented ERA-EDTA Registry data evaluated the frequency of dialysis, kidney transplantation, and comprehensive conservative management for patients with kidney failure in Europe. Kidney Int 2021;100:182-95.
de Jong RW, Stel VS, Rahmel A, Murphy M, Vanholder RC, Massy ZA, et al. Patient-reported factors influencing the choice of their kidney replacement treatment modality. Nephrol Dial Transplant 2022;37:477-88.
Joosten EA, DeFuentes-Merillas L, de Weert GH, van de Staak CPF, de Jong CAJ. Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom 2008;77:219-26.
European Patients Academy on Therapeutic Innovation (EUPATI). Education that empowers [Internet]. 2026. [cited 2026 Jan 12]. Available from: https:// eupati.eu/
Sever MS, Luyckx V, Tonelli M, kazancioglu R, Rodgers D, Gallego D, et al. Disasters and kidney care: pitfalls and solutions. Nat Rev Nephrol 2023;19:672- 86.
Pawlowicz-Szlarska E, Vanholder R, Sever MS, Tuglular S, Luyckx V, Eckardt K, et al. Distribution, preparedness and management of Ukrainian adult refugees on dialysis-an international survey by the Renal Disaster Relief Task Force of the European Renal Association. Nephrol Dial Transplant 2023;38:2407-15.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Insight Urology

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.